The future of the Texas Compassionate Use Program, which will allow some physicians to treat epilepsy with cannabinoid -based drugs, is right here at the Texas Medical Center. At a meeting in early January, Vyripharm Biopharmaceuticals explained to a group of politicians, decision makers and … Read More
The post Vyripharm helping standardize cannabinoid -based drugs in Texas appeared first on Dagga Magazine.